JavaScript NENÍ povolen !

Prosím povolte JavaScript.

Článek

PubMed

Záznam pochází z PubMed

Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

JACC. Cardiovascular interventions. 2024 Feb 12 ; 17 (3) : 374-387. [epub] 20240103

JACC Cardiovasc Interv
ISSN 1876-7605 | 1936-8798
Zdroj

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz https://www.medvik.cz/link/pmid38180419

PubMed 38180419
DOI 10.1016/j.jcin.2023.10.041
PII: S1936-8798(23)01436-X
Knihovny.cz E-zdroje

Klíčová slova
aortic valve stenosis, coronavirus disease 2019, transcatheter aortic valve replacement, valvular heart disease,
MeSH
aortální chlopeň diagnostické zobrazování chirurgie MeSH
aortální stenóza * diagnostické zobrazování chirurgie epidemiologie MeSH
COVID-19 * epidemiologie MeSH
lidé MeSH
pandemie MeSH
registrace MeSH
rizikové faktory MeSH
transkatetrální implantace aortální chlopně * škodlivé účinky metody MeSH
výsledek terapie MeSH
Check Tag
lidé MeSH
Publikační typ
časopisecké články MeSH

BACKGROUND: The COVID-19 pandemic adversely affected health care systems. Patients in need of transcatheter aortic valve replacement (TAVR) are especially susceptible to treatment delays. OBJECTIVES: This study sought to evaluate the impact of the COVID-19 pandemic on global TAVR activity. METHODS: This international registry reported monthly TAVR case volume in participating institutions prior to and during the COVID-19 pandemic (January 2018 to December 2021). Hospital-level information on public vs private, urban vs rural, and TAVR volume was collected, as was country-level information on socioeconomic status, COVID-19 incidence, and governmental public health responses. RESULTS: We included 130 centers from 61 countries, including 65,980 TAVR procedures. The first and second pandemic waves were associated with a significant reduction of 15% (P < 0.001) and 7% (P < 0.001) in monthly TAVR case volume, respectively, compared with the prepandemic period. The third pandemic wave was not associated with reduced TAVR activity. A greater reduction in TAVR activity was observed in Africa (-52%; P = 0.001), Central-South America (-33%; P < 0.001), and Asia (-29%; P < 0.001). Private hospitals (P = 0.005), urban areas (P = 0.011), low-volume centers (P = 0.002), countries with lower development (P < 0.001) and economic status (P < 0.001), higher COVID-19 incidence (P < 0.001), and more stringent public health restrictions (P < 0.001) experienced a greater reduction in TAVR activity. CONCLUSIONS: TAVR procedural volume declined substantially during the first and second waves of the COVID-19 pandemic, especially in Africa, Central-South America, and Asia. National socioeconomic status, COVID-19 incidence, and public health responses were associated with treatment delays. This information should inform public health policy in case of future global health crises.

Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

Najít záznam

Citační ukazatele

Možnosti archivace